FibroBiologics Inc’s recent filing unveils that its Chief Scientific Officer Khoja Hamid acquired Company’s shares for reported $16800.0 on May 27 ’25. In the deal valued at $0.84 per share,20,000 shares were bought. As a result of this transaction, Khoja Hamid now holds 31,250 shares worth roughly $29375.0.
Then, O’HEERON PETE bought 8,500 shares, generating $16,269 in total proceeds. Upon buying the shares at $1.91, the Chief Executive Officer now owns 6,056,647 shares.
Before that, Khoja Hamid bought 10,000 shares. FibroBiologics Inc shares valued at $19,000 were divested by the Chief Scientific Officer at a price of $1.90 per share. As a result of the transaction, Khoja Hamid now holds 11,250 shares, worth roughly $10575.0.
Rodman & Renshaw initiated its FibroBiologics Inc [FBLG] rating to a Buy in a research note published on December 12, 2024; the price target was $12. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Maxim Group began covering FBLG with “Buy” recommendation on September 24, 2024.
Price Performance Review of FBLG
On Tuesday, FibroBiologics Inc [NASDAQ:FBLG] saw its stock fall -0.93% to $0.94. Over the last five days, the stock has gained 18.71%. FibroBiologics Inc shares have fallen nearly -53.20% since the year began. Nevertheless, the stocks have fallen -90.92% over the past one year.
How much short interest is there in FibroBiologics Inc?
A steep rise in short interest was recorded in FibroBiologics Inc stocks on 2025-05-15, growing by 39165.0 shares to a total of 1.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 1.53 million shares. There was a rise of 2.5%, which implies that there is a positive sentiment for the stock.
